Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Long term survivors in the era of immunotherapy of cancer

Cognitive defects in long term IO

Date

23 Oct 2023

Session

Long term survivors in the era of immunotherapy of cancer

Topics

Multi-Disciplinary and Multi-Professional Cancer Care; Psycho-Oncology; Immunotherapy; Survivorship

Tumour Site

Melanoma

Presenters

Anne Rogiers

Authors

A. Rogiers

Author affiliations

Psychiatry, CHU Brugmann UVB, 1020 - Brussels/BE

Resources

This content is available to ESMO members and event participants.

Login

Resources from the same session

23 Oct 2023

Long-term toxicity of immunotherapeutics

Presenter: David McDermott

Session: Long term survivors in the era of immunotherapy of cancer

Resources:

Slides

Webcast

23 Oct 2023

Quality of life in IO-treated long-term survivors

Presenter: Lonneke Van De Poll-franse

Session: Long term survivors in the era of immunotherapy of cancer

Resources:

Slides

Webcast

23 Oct 2023

Ideal duration of IT: How to define it and what are the implications

Presenter: Teresa Amaral

Session: Long term survivors in the era of immunotherapy of cancer

Resources:

Slides

Webcast

23 Oct 2023

Discussion

Presenter: All Speakers

Session: Long term survivors in the era of immunotherapy of cancer

Resources:

Slides

Webcast